Cargando…
Promises and challenges of mucosal COVID-19 vaccines
Coronavirus disease-2019 (COVID-19) is an ongoing pandemic caused by the newly emerged virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, COVID-19 vaccines are given intramuscularly and they have been shown to evoke systemic immune responses that are highly efficacious to...
Autores principales: | Rathore, Abhay P.S., St. John, Ashley L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083204/ https://www.ncbi.nlm.nih.gov/pubmed/37045682 http://dx.doi.org/10.1016/j.vaccine.2023.04.013 |
Ejemplares similares
-
Protective and pathogenic roles for mast cells during viral infections
por: Rathore, Abhay PS, et al.
Publicado: (2020) -
Dengue: Update on Clinically Relevant Therapeutic Strategies and Vaccines
por: Palanichamy Kala, Monica, et al.
Publicado: (2023) -
Immune responses to dengue virus in the skin
por: Rathore, Abhay P. S., et al.
Publicado: (2018) -
Cross-Reactive Immunity Among Flaviviruses
por: Rathore, Abhay P. S., et al.
Publicado: (2020) -
Challenges in mucosal vaccination of cattle
por: Shewen, P.E., et al.
Publicado: (2009)